{"DataElement":{"publicId":"5782289","version":"1","preferredName":"Health Care Provider Instruction Six Mercaptopurine Take In The Evening Data Unknown Text","preferredDefinition":"A single character text field to indicate if there was an instruction by a health care provider to take 6MP in the evening.","longName":"5782288v1.0:2200608v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"5782288","version":"1","preferredName":"Health Care Provider Instruction Six Mercaptopurine Take In The Evening","preferredDefinition":"Persons who provides health care as part of their job responsibilities: or a person or organization who is licensed to supply health care._A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one._A thiopurine-derivative antimetabolite with antineoplastic and immunosuppressive activities.  Produced through the metabolism of mercaptopurine by hypoxanthine-guanine phosphoribosyltransferase (HGPRT), mercaptopurine metabolites 6-thioguanosine-5'-phosphate (6-thioGMP) and 6-thioinosine monophosphate (T-IMP) inhibit nucleotide interconversions and de novo purine synthesis, thereby blocking the formation of purine nucleotides and inhibiting DNA synthesis.  This agent is also incorporated into DNA in the form of deoxythioguanosine, which results in the disruption of DNA replication. In addition, mercaptopurine is converted to 6-methylmercaptopurine ribonucleoside (MMPR) by 6-thiopurine methyltransferase; MMPRs are also potent inhibitors of de novo purine synthesis. (NCI04)_As pertains to a medication: ingest, inhale, instill, or inject._A message describing how something is to be done._The time period between late afternoon and bedtime.","longName":"2675185v1.0:5782286v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2675185","version":"1","preferredName":"Health Care Provider","preferredDefinition":"Persons who provides health care as part of their job responsibilities, or a person or organization who is licensed to supply health care.","longName":"C16666","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Health Care Provider","conceptCode":"C16666","definition":"Persons who provides health care as part of their job responsibilities: or a person or organization who is licensed to supply health care.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"38ECCF1F-F40A-71E0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-08-30","modifiedBy":"ONEDATA","dateModified":"2007-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5782286","version":"1","preferredName":"Six Mercaptopurine Take Evening Instruction","preferredDefinition":"A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.:A thiopurine-derivative antimetabolite with antineoplastic and immunosuppressive activities.  Produced through the metabolism of mercaptopurine by hypoxanthine-guanine phosphoribosyltransferase (HGPRT), mercaptopurine metabolites 6-thioguanosine-5'-phosphate (6-thioGMP) and 6-thioinosine monophosphate (T-IMP) inhibit nucleotide interconversions and de novo purine synthesis, thereby blocking the formation of purine nucleotides and inhibiting DNA synthesis.  This agent is also incorporated into DNA in the form of deoxythioguanosine, which results in the disruption of DNA replication. In addition, mercaptopurine is converted to 6-methylmercaptopurine ribonucleoside (MMPR) by 6-thiopurine methyltransferase; MMPRs are also potent inhibitors of de novo purine synthesis. (NCI04):As pertains to a medication: ingest, inhale, instill, or inject.:The time period between late afternoon and bedtime.:A message describing how something is to be done.","longName":"5782286v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Six","conceptCode":"C66837","definition":"A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Mercaptopurine","conceptCode":"C195","definition":"A thiopurine-derivative antimetabolite with antineoplastic and immunosuppressive activities.  Produced through the metabolism of mercaptopurine by hypoxanthine-guanine phosphoribosyltransferase (HGPRT), mercaptopurine metabolites 6-thioguanosine-5'-phosphate (6-thioGMP) and 6-thioinosine monophosphate (T-IMP) inhibit nucleotide interconversions and de novo purine synthesis, thereby blocking the formation of purine nucleotides and inhibiting DNA synthesis.  This agent is also incorporated into DNA in the form of deoxythioguanosine, which results in the disruption of DNA replication. In addition, mercaptopurine is converted to 6-methylmercaptopurine ribonucleoside (MMPR) by 6-thiopurine methyltransferase; MMPRs are also potent inhibitors of de novo purine synthesis. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Take","conceptCode":"C65105","definition":"As pertains to a medication: ingest, inhale, instill, or inject.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Evening","conceptCode":"C64936","definition":"The time period between late afternoon and bedtime.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Instruction","conceptCode":"C42688","definition":"A message describing how something is to be done.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E17C3FC-2945-47F5-E053-F662850AE578","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E17C3FC-2956-47F5-E053-F662850AE578","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"MORENOC","dateModified":"2017-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2200608","version":"1","preferredName":"Data Unknown Text","preferredDefinition":"a single character text field to record data.","longName":"DATA_UNKNOWN_TEXT","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1B9DBEC-1A57-2AD7-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-07","modifiedBy":"ALAIS","dateModified":"2009-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Take in the evening","type":"Preferred Question Text","description":"Take in the evening","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E17CBCA-F8C8-576D-E053-F662850AED52","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-26","modifiedBy":"MORENOC","dateModified":"2017-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}